News Releases

September 1, 2015

RepliCel Life Sciences Cleared to Initiate Clinical Trial of RCS-01 for Dermal Rejuvenation
Patient recruitment will take place at the IUF Leibniz-Institut für umweltmedizinische Forschung GmbH in Germany VANCOUVER, BC – September 1, 2015 – RepliCel Life... Read full article

August 28, 2015

RepliCel Reports Second Quarter 2015 Financial Results
VANCOUVER, BC – August 28, 2015 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP), a clinical stage regenerative medicine company focused on the... Read full article

August 3, 2015

RepliCel Presenting at InvestMNT Investor Conference in Minneapolis
Conference attracts investment professionals in the Twin Cities area VANCOUVER, BC – August 3, 2015 – RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: REPCF),... Read full article

July 29, 2015

RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype
Novel features of next-generation design promise to serve and expand the dermal injectable market VANCOUVER, BC – July 29, 2015 – RepliCel Life Sciences... Read full article

July 21, 2015

RepliCel Receives Two Important Approvals for Dermal Rejuvenation Clinical Trial
German-based trial to test RCS-01 cell therapy treatment for aged and sun-damaged skin VANCOUVER, BC – July 21, 2015 – RepliCel Life Sciences Inc.... Read full article

June 30, 2015

RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis
ReaCT Trial at University of British Columbia Treating Patients with Autologous Cell Therapy VANCOUVER, BC – June 30, 2015 – RepliCel Life Sciences Inc.... Read full article

June 26, 2015

RepliCel Life Sciences Inc. Announces Closing of Brokered and Non-brokered Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC – June 26, 2015 – RepliCel... Read full article

June 5, 2015

RepliCel Life Sciences Announces Participation in 23rd World Congress of Dermatology, Vancouver, BC
Conference program to include presentations on the clinical development of RepliCel’s skin rejuvenation, hair regeneration, and tendon repair technologies VANCOUVER, BC – June 5,... Read full article

June 1, 2015

RepliCel Life Sciences Announces Brokered Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC – June 1, 2015 – RepliCel... Read full article

May 20, 2015

RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference
Clinical trial at the University of British Columbia now recruiting patients VANCOUVER, BC – May 21, 2015 – RepliCel Life Sciences Inc. (TSX.V: RP)... Read full article